Brain imaging shows how cannabis odor cues activate reward regions in at-risk young adults

An fMRI study found that young adults at risk for cannabis use disorder showed heightened brain activation in reward regions when exposed to cannabis-related odor cues.

Kleinhans, Natalia M et al.·Brain and behavior·2020·Preliminary EvidenceCross-Sectional
RTHC-02649Cross SectionalPreliminary Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Preliminary Evidence
Sample
N=54

What This Study Found

Using fMRI, researchers found that young adults with higher cannabis use disorder risk showed greater activation in the ventral striatum and orbitofrontal cortex when exposed to cannabis odor cues compared to neutral odors. This pattern mirrors cue-reactivity findings seen in other substance use disorders.

Key Numbers

54 participants; heightened activation in ventral striatum and orbitofrontal cortex to cannabis odor cues in higher-risk individuals.

How They Did This

Cross-sectional fMRI study with 54 young adult cannabis users exposed to cannabis-related and neutral odor cues during brain scanning. CUD risk was assessed using validated screening tools.

Why This Research Matters

Understanding how cannabis cues activate the brain in at-risk users could help identify who is most vulnerable to developing problematic use and inform cue-exposure based treatments.

The Bigger Picture

Cue-reactivity (strong brain responses to substance-related cues) is a hallmark of addiction neuroscience. Finding this pattern for cannabis odor cues suggests that problematic cannabis use shares neural mechanisms with other substance use disorders.

What This Study Doesn't Tell Us

Cross-sectional design cannot determine whether heightened cue-reactivity causes or results from heavier use. Moderate sample size. Odor cues may not capture the full range of real-world cannabis triggers.

Questions This Raises

  • ?Could cue-reactivity fMRI serve as a biomarker for CUD risk?
  • ?Would cue-exposure therapy reduce this heightened reactivity over time?

Trust & Context

Key Stat:
Higher CUD risk linked to greater ventral striatum activation to cannabis odors
Evidence Grade:
Preliminary: cross-sectional fMRI with moderate sample size; cannot establish directionality.
Study Age:
Published 2020.
Original Title:
FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder.
Published In:
Brain and behavior, 10(10), e01764 (2020)
Database ID:
RTHC-02649

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What brain regions responded to cannabis odor cues?

The ventral striatum (involved in reward processing) and orbitofrontal cortex (involved in decision-making and value assessment) showed heightened activation in higher-risk individuals.

Does this mean cannabis is addictive in the same way as other drugs?

The study found similar cue-reactivity patterns to those seen in other substance use disorders, suggesting shared neural mechanisms, but this does not mean the addiction profiles are identical.

Read More on RethinkTHC

Cite This Study

RTHC-02649·https://rethinkthc.com/research/RTHC-02649

APA

Kleinhans, Natalia M; Sweigert, Julia; Blake, Matthew; Douglass, Bradley; Doane, Braden; Reitz, Fredrick; Larimer, Mary. (2020). FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder.. Brain and behavior, 10(10), e01764. https://doi.org/10.1002/brb3.1764

MLA

Kleinhans, Natalia M, et al. "FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder.." Brain and behavior, 2020. https://doi.org/10.1002/brb3.1764

RethinkTHC

RethinkTHC Research Database. "FMRI activation to cannabis odor cues is altered in individu..." RTHC-02649. Retrieved from https://rethinkthc.com/research/kleinhans-2020-fmri-activation-to-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.